Document is current

Any future updates will be listed below

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

Crossref DOI link: https://doi.org/10.1186/s13030-017-0093-9

Published Online: 2017-03-16

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark